Kintara Therapeutics Total Current Liabilities

Kintara Therapeutics (KTRA) currently reports a total current liabilities of $6.1M as of March 2026. That compares with $4.8M in the prior-year period — up 26.9% year over year. Use the charts on this page to explore Kintara Therapeutics's total current liabilities history and peer comparisons.

Kintara Therapeutics's total current liabilities increased from $4.8M to $6.1M — a 26.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kintara Therapeutics reported $6.1M in total current liabilities as of March 2026. That compares with $4.8M in the prior-year period — up 26.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $6.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kintara Therapeutics, and consider following KTRA for alerts when major investors trade the stock.

Kintara Therapeutics is classified in the Materials sector. On total current liabilities, it currently shows $6.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing KTRA with unrelated industries.